Robb Jutton took a chance on an experimental cancer treatment. It could’ve cost him his life. Instead, it saved him.
But there was a sliver of hope: an experimental treatment that only a handful of patients around the world had tried. It involved using a drug off-label and had serious risks associated with it, but Jutton, 51, opted in. He called it “a no-brainer.”
... [8092 chars]